Effect of contraceptive hormonal therapy on mammographic breast density: A longitudinal cohort study

Clin Imaging. 2023 May:97:62-67. doi: 10.1016/j.clinimag.2023.03.001. Epub 2023 Mar 6.

Abstract

Purpose: Evaluate the longitudinal relationship between mammographic density and hormonal contraceptive use in late reproductive-aged women.

Methods: Patients aged 35-50 years old who underwent 5 or more screening mammograms within a 7.5-year period between 2004 and 2019 in a single urban tertiary care center were randomly selected. Patients were categorized into four cohorts based on hormonal contraceptive exposure during a 2-year lead-in period and a 7.5-year study period: 1) never exposed, 2) always exposed, 3) interval hormonal contraceptive start, and 4) interval hormonal contraceptive stop. The primary outcome was difference in BI-RADS breast density category between initial and final mammograms.

Results: Of the 708 patients included, long-term use of combined oral contraceptives or a levonorgestrel intrauterine device were not associated with an increase in breast density category over the 7.5-year study period, compared to those with no hormonal contraceptive exposure. Initiation of combined oral contraceptives was associated with an increase in breast density category (β = 0.31, P = 0.045); however, no difference in initial density category was noted between those exposed and those never exposed to combined oral contraceptives during the 2-year lead-in period, and discontinuation was not associated with a decrease in breast density category when compared to those with continuous exposure.

Conclusion(s): Long-term use of combined oral contraceptives or a levonorgestrel intrauterine device was not associated with an increase in BI-RADS breast density category. Initiation of a combined oral contraceptive was associated with an increase in breast density category, although this may be a transient effect.

Keywords: BI-RADS; Birth control; Breast cancer screening; Breast density; Hormonal contraception; Mammography.

MeSH terms

  • Adult
  • Breast Density
  • Cohort Studies
  • Contraceptives, Oral, Combined*
  • Female
  • Humans
  • Levonorgestrel* / adverse effects
  • Longitudinal Studies
  • Middle Aged

Substances

  • Levonorgestrel
  • Contraceptives, Oral, Combined